期刊文献+

抑制miR-155表达对白血病细胞系THP-1的增殖和凋亡影响及作用机制 被引量:4

Efects of Inhibiting miR-155 Expression on the Proliferation and Apoptosis of Leukemia THP-1 Cells
下载PDF
导出
摘要 本研究通过转染miR-155抑制物(inhibitor)下调THP-1细胞的miR-155表达,探讨抑制miR-155表达对THP-1细胞增殖及凋亡的影响及其机制。通过X-treme GENE siRNA Transfection Reagent在THP-1细胞转染miR-155 inhibitor(THP-1I),同时设置未转染组(THP-1C)和转染对照组(THP-1IC);应用实时定量PCR(RT-PCR)检测miR-155转染效率及转染后SHIP1的mRNA基因水平的表达,应用CCK-8法检测对细胞系增殖的影响,流式细胞术检测对凋亡的影响,Western blot法检测转染后的SHIP1、AKT、p AKT蛋白水平的基因表达。结果表明,与THP-1C和THP-1IC相比,THP-1I的miR-155表达水平明显降低(P<0.05);抑制miR-155可导致THP-1细胞的凋亡率明显增高(P<0.05);抑制miR-155对THP-1细胞的SHIP1 mRNA含量无明显影响,但导致SHIP1蛋白水平明显升高(P<0.05),提示miR-155对THP-1细胞的SHIP1可能存在翻译水平的调节;miR-155抑制尽管未导致总AKT(TAKT)的蛋白含量变化,但p AKT蛋白水平明显降低(P<0.05)。结论:抑制miR-155表达可能通过增加SHIP1蛋白含量和抑制PI3K/AKT信号途径促进THP-1细胞凋亡,提示抑制miR-155可能成为抗白血病治疗的新策略。 The aim of this study was to investigate the effects of miR-155 inhibitor transfection on the proliferation and apoptosis of THP-1 cells.The miR-155 inhibitor was transfected into THP-1 cells( THP-1)Iby using X-treme GENE siRNA transfection reagent.Cells without transfection( THP-1Cand cells with negative transfection( THP-1IC)were used as controls.Quantitative real-time polymerase chain reaction( RT-PCR)was performed to detect the expression of miR-155 and relative expression of SHIP1 mRNA in the cells.Cell proliferation was assayed using CCK-8method.Cell apoptosis were detected by flow cytometry.The expression of SHIP1 TAKT and pAKT in THP-1 cells were detected by Western blot.The results indicated that compared with THP-1C and THP-1ICthe expression of miR-155 in THP-1I cells was significantly reducedmiR-155 inhibition significantly increased apoptosis rate in THP-1 cells(P〈0.05); miR-155 inhibition in THP-1 cells caused no significant alteration in SHIP1 mRNA level but significantly increased its protein contentindicating some post-transcriptional modulations might exist underlying the modulation of miR-155 to SHIP1 the miR-155 caused significantly reduced protein level of pAKT( P〈0.05) without interfering TAKT protein content.It is concluded that the miR-155 inhibition may promote THP-1 cell apoptosis through increasing SHIP1 protein content and impairing its downstream PI3 K /AKT signaling pathway.This study suggests that miR-155 inhibition may be a promising therapy strategy for treating acute myeloid leukemia(AML).
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第6期1550-1554,共5页 Journal of Experimental Hematology
关键词 白血病 MIR-155 THP-1细胞 细胞增殖 细胞凋亡 leukemia miR-155 THP-1 cell cell proliferation cell apoptosis
  • 相关文献

参考文献15

  • 1Huntzinger E,Izaurralde E.Gene silencing by microRNAs:contributions of translational repression and mRNA decay.Nat Rev Genet,2011,12(2):99-110.
  • 2薛华,化罗明,罗建民.miRNA-155与恶性血液病[J].中国实验血液学杂志,2013,21(3):810-814. 被引量:5
  • 3Whitman SP,Maharry K,Radmacher MD,et al.FLT3 internal tandem duplication associates with adverse outcome and gene and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia:a cancer and leukemia group B study.Blood,2010,116(18):3622-3626.
  • 4Marcucci G,Maharry KS,Metzeler KH,et al.Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia:miR-155upregulation independently identifies high-risk patients.J Clin Oncol,2013,31(17):2086-2093.
  • 5O'Connell RM,Rao DS,Chaudhuri AA,et al.Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloprolierative disorder.J Exp Med,2008,205(3):585-594.
  • 6Danen-van Oorschot AA,Kuipers JE,Arentsen-Peters S,et al.Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.Pediatr Blood Cancer,2011,58(5):715-721.
  • 7Yamanaka Y,Tagawa H,Takahashi N,et al.Aberrant overexpression of microRNAs activate AKT signaling via downregulation of tumor suppressors in natural killer cell lymphoma/leukemia.Blood,2009,114(15):3265-3275.
  • 8Poltronieri P,D'Urso PI,Mez2011a V,et al.Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours.Chem Biol Drug Des,2013,81(1):79-84.
  • 9Sun Y,Wang M,Lin G,et al.Serum microRNA-155 as a potential biomarker to track disease in breast cancer.PLo S One,2012,7(10):e47003.
  • 10Pedersen IM,Otero D,Kao E,et al.Onco-miR-155 targets SHIP1to promote TNFa-dependent growth of B cell lymphomas.EMBO Mol Med,2009,1(5):288-295.

二级参考文献41

  • 1Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contri- butions of translational repression and mRNA decay. Nat Rev Genet, 2011 ;12(2) :99 - 110.
  • 2Faraoni I, Antonetti FR, Cardone J,et al. miR-155 gene: a typical multifunctional micmRNA. Biochim Biophys Acta, 2009 ; 1792 ( 6 ) : 497 - 505.
  • 3OConnell RM,Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell develop- ment. Immunity, 2010;33(4) :607 -619.
  • 4Cremer T], Fatehchand K, Shah P, et al. MiR-155 Induction by Microbes/Microbial Ligands Requires NF-KB-Dependent de novo Protein Synthesis. Front Cell Infect Microbio1,2012; 73 (2) :1 -13.
  • 5Spierings DC, McGoldrick D, Hamilton-Easton AM, et al. Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood,2011 ; 117 (20) :5340 - 5349.
  • 6Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large B cell lymphoma. Br J Haemato1,2008 ; 141 (5) : 672 - 675.
  • 7Huang X, Shen Y, Liu M, et al. Quantitative proteomics reveals that miR-155 regulates the PBK-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol,2012;181(1 ) :26 -33.
  • 8Kluiver J, Poppema S, de Jong D, et al. BIC and miR-155 are high- ly expressed "in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol, 2005 ;207(2) :243 -249.
  • 9Marton S, gareia MR, Robello C, et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia, 2008 ; 22(2) : 330 -338.
  • 10Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of turnout-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol, 2008;141 (5) :672- 675.

共引文献18

同被引文献15

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部